Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date-Reference-Cited by-同舟云学术

Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date

Published:2016-10-14 Issue:11 Volume:70 Page:886-897
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

McCormack Terry¹,Dent Ricardo²,Blagden Mark³

Affiliation:

1. Hull York Medical School Whitby Group Practice Spring Vale Medical Centre Whitby UK

2. Amgen (Europe) GmbH Zug Switzerland

3. Ashgate Medical Practice Chesterfield UK

Funder

Amgen (Europe) GmbH

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12881

Reference77 articles.

1. NicholsM TownsendN Luengo‐FernandezR et al.European Cardiovascular Disease Statistics 2012. European Heart Network Brussels European Society of Cardiology Sophia Antipolis 2012.http://www.ehnheart.org/cvd-statistics.html. Accessed January 8 2016.

2. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

3. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

4. NICE clinical guideline on lipid modification 2014.https://www.nice.org.uk/guidance/cg181. Accessed May 20 2016.

5. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Association between Low-Density Lipoprotein Subfractions and Major Adverse Cardiovascular Outcomes—A Comprehensive Review;International Journal of Molecular Sciences;2023-04-03

2. Advances in engineering the production of the natural red pigment lycopene: A systematic review from a biotechnology perspective;Journal of Advanced Research;2023-04

3. 2022 Saudi guidelines for the management of dyslipidemia;HEART VIEWS;2023

4. Serum Lipid Variation in Patients with Dengue Virus Infection and Associated Risks of Cardio Vascular Disorder;Albus Scientia;2022-10-03

5. The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy;Journal of Clinical Medicine;2022-01-18